Anthem Biosciences' IPO ended on 16 July, with the issue booked over 60 times. Strong demand from qualified institutional ...

Anthem Biosciences IPO oversubscribed 63.86 times, attracting strong QIB support, raising ₹1,016 crore from anchor investors.

Today is the last day for investors to subscribe for the Anthem Biosciences IPO, which so far has gathered a lot of attention ...

Anthem Biosciences Ltd's IPO was subscribed 63.86 times by closing day, driven by institutional buyers. The Rs 3,395-crore ...

Following the close of the subscription of initial public offering (IPO) of Anthem Biosciences Limited, all eyes of the ...

Anthem Biosciences IPO GMP surged on Wednesday as the Rs 3,395-crore initial share saw robust subscription on the concluding ...

Indian drugmaker Anthem Biosciences' ANTH.NS $395 million IPO was fully subscribed on the second day of bidding on Tuesday, ...

Anthem Biosciences' Rs 3,395 crore IPO was subscribed 63.86 times, exceeding expectations. QIBs showed strong interest, while ...

Anthem Biosciences IPO closes today; check GMP, latest subscription stats, and key dates -act now before bidding ends!

The initial public offering of Anthem Biosciences Ltd. has been subscribed to nearly eight times the offer on its third and ...

Check latest subscription status, grey market premium (GMP), allotment date, listing date, and other key details here ...

Anthem Biosciences, ₹3,395 crore IPO was fully subscribed by Day 2, with strong interest from non-institutional investors, ...